IPCA-Zopiclone

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Zopiclone 3.75mg;  

Commercializzato da:

Ipca Pharma (NZ) Pty Limited

INN (Nome Internazionale):

Zopiclone 3.75 mg

Dosaggio:

3.75 mg

Forma farmaceutica:

Film coated tablet

Composizione:

Active: Zopiclone 3.75mg   Excipient: Calcium hydrogen phosphate dihydrate Colloidal silicon dioxide Hypromellose Indigo carmine aluminium lake Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Povidone Purified talc Sodium starch glycolate Titanium dioxide

Tipo di ricetta:

Class C5 Controlled Drug

Prodotto da:

Centaur Pharmaceuticals Private Limited

Indicazioni terapeutiche:

Treatment of transient, short-term and chronic insomnia in adults including difficulties with falling asleep, nocturnal awakening and wakening.

Dettagli prodotto:

Package - Contents - Shelf Life: Blister pack, PVC/Al in outer cardboard carton - 28 tablets - 36 months from date of manufacture stored at or below 25°C protect from light

Data dell'autorizzazione:

2013-06-14